Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Cboe Europe  -  09:01:56 2023-06-06 am EDT
1124.10 DKK   +3.99%
05:57aNovo Nordisk A/S – Share repurchase programme
GL
05:20aEuropean shares flat on rate-hike jitters; Novo Nordisk jumps
RE
06/05Global markets live: Walt Disney, Chevron, 3M, Lufthansa, BYD...
MS
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
05/30/2023 05/31/2023 06/01/2023 06/02/2023 06/06/2023 Date
1116(c) 1116.2(c) 1098.6(c) 1081(c) 1124.6 Last
1 196 069 3 586 673 1 401 308 2 055 716 945 986 Volume
-1.90% +0.02% -1.58% -1.60% +4.03% Change
More quotes
Estimated financial data (e)
Sales 2023 222 B 31 973 M 31 973 M
Net income 2023 78 204 M 11 247 M 11 247 M
Net cash position 2023 18 156 M 2 611 M 2 611 M
P/E ratio 2023 31,0x
Yield 2023 1,51%
Sales 2024 259 B 37 224 M 37 224 M
Net income 2024 89 524 M 12 875 M 12 875 M
Net cash position 2024 36 303 M 5 221 M 5 221 M
P/E ratio 2024 26,7x
Yield 2024 1,76%
Capitalization 2 425 B 349 B 349 B
EV / Sales 2023 10,8x
EV / Sales 2024 9,23x
Nbr of Employees 57 089
Free-Float 74,8%
More Financials
Company
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes treatment products (78.9%); - rare disease treatment products (11.6%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.; - obesity treatment products (9.5%). Net sales are distributed geographically as follows:... 
Read more
Sector
Pharmaceuticals
Calendar
06/25 | 10:30pmPresentation
More about the company
Ratings of Novo Nordisk A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about NOVO NORDISK A/S
05:57aNovo Nordisk A/S – Share repurchase programme
GL
05:20aEuropean shares flat on rate-hike jitters; Novo Nordisk jumps
RE
06/05Global markets live: Walt Disney, Chevron, 3M, Lufthansa, BYD...
MS
06/05Oil Output Cut, Interest Rates in Focus Amid Mixed Exchange-Traded Funds, Equity Future..
MT
06/05Akero says NASH drug shown to reduce liver fat by 65% in some patients
RE
06/05Novo Nordisk in Talks to Acquire Controlling Stake in Biocorp
MT
06/05Denmark's Novo Nordisk to Buy Controlling Stake in French Delivery Systems Group Biocor..
MT
06/05Novo Nordisk In Talks to Buy Biocorp in EUR154 Million Deal
DJ
06/05Novo Nordisk in talks buy controlling stake in Biocorp
RE
06/05Novo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, t..
GL
06/05Novo Nordisk Enters into Exclusive Negotiations to Acquire A Controlling Stake in Bicor..
CI
06/02European Equities Traded as American Depositary Receipts Move Higher in Friday US Tradi..
MT
06/02US Futures, European Stocks Rise Ahead of Jobs Data
DJ
06/01FDA warns about safety risks of tailored weight-loss drugs
RE
06/01FDA warns about safety risks of tailored weight-loss drugs
RE
More news
News in other languages on NOVO NORDISK A/S
08:20aLes actions dans le rouge, craintes pour l'économie, le pétrole rechute
07:53aLes marchés actions en position d'attente
07:46aPoint marchés-Les actions dans le rouge, craintes pour l'économie, le pétrole rechute
07:13aBörsen kommen kaum vom Fleck - Warten auf Impulse
05:46aBorse Europa piatte su incertezze rialzi tassi, sale Novo Nordisk
More news
Analyst Recommendations on NOVO NORDISK A/S
More recommendations
Stock Trading Strategies
NOVO NORDISK A/S - 02/28
The underlying trend is to the upside
BUY
More Stock Trading Analysis
ETFs positioned on NOVO NORDISK A/SETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
XACT NORDEN () - SEK21.31%0.77%-Nordic
Xtrackers MSCI Nordic 1D - EUR19.56%-0.01%Nordic
Xtrackers MSCI Europe Health Care ESG Scree...15.91%-0.75%-NC
SPDR MSCI Europe Health Care - EUR15.91%-0.66%-NC
IShares MSCI Europe Health Care Sector Acc - EUR15.88%-0.88%-NC
More ETFs positioned on NOVO NORDISK A/S
Analysis
Novo Nordisk in talks buy controlling stake in Biocorp
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 1 081,00 DKK
Average target price 1 143,05 DKK
Spread / Average Target 5,74%
EPS Revisions
Managers and Directors
Lars Fruergaard Jørgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Henrik Ehlers Wulff Senior Vice President-Diabetes API
Stephen Gough Global Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S15.25%348 728
JOHNSON & JOHNSON-11.14%442 895
ELI LILLY AND COMPANY20.74%421 724
MERCK & CO., INC.1.95%287 009
ROCHE HOLDING AG0.33%259 497
ABBVIE INC.-15.31%241 461
Stock markets for all
100% Free Registration
fermer